Background
- Includes a spectrum of molecules that hydrolyze β-lactams, from penicillins to carbapenems
Ambler Classification
- Classification based on amino acid sequences rather than function
| Class
|
Binding Site
|
Examples
|
Inhibitors
|
| A
|
serine
|
TEM, SHV, KPC, CTX-M, GES
|
clavulanic acid, tazobactam, avibactam, vaborbactam, relebactam
|
| B
|
metallo
|
VIM, NDM, IMP
|
|
| C
|
serine
|
AmpC, P99
|
avibactam, vaborbactam, relebactam
|
| D
|
serine
|
OXA (oxacillinase) enzymes
|
avibactam (OXA-48), ±clavulanic aciid
|
Serine β-lactamases
- Amber classes A, B, and C are the serine β-lactamases
- Contain a serine residue at the active site
- Class A: inhibited by clavulanic acid or tazobactam
- Constitutively expressed plasmid
- Most common ESBL in Gram-negative bacteria
- Resistance to 2nd and 3rd generation cephalosporins
- Common in E. coli, Klebsiella, and Proteus spp.
- Examples include:
- Penicillinases: TEM-1 (common in GNBs), SHV-1
- ESBLs: CTX-M, TEM-3
- Carbapenemases: K. pneumoniae carbapenemase (KPC)
- Class C: not inhibited by clavulanic acid or EDTA, resistant to cefoxitin, inhibited by cloxicillin in vitro
- Class D: not inhibited by EDTA, variably inhibited by clavulanic acid; hard to identify
- Common in Pseudomonas
- Difficult to detect with routine screening
- Examples include:
- ESBLs: OXA-11
- Carbapenemases: OXA-23, OXA-48
- Ambler Class B are the metallo-β-lactamases
- Contain a zinc ion at the active site
- Inhibited by EDTA, not inhibited by clavulanic acid
- Examples include:
- Carbapenemases:
- New Delhi metallo-beta-lactamase (NDM-1)
- Imipenemases (IMP)
- Verona integron-encoded metallo-β-lactamases (VIM)
- L1 β-lactamase, present in the Stenotrophomonas maltophilia chromosome
Bush-Jacoby Classification
| Group
|
Ambler
|
Substrates
|
Inhibitors
|
Definition
|
Examples
|
| CA/TZB
|
EDTA
|
| Group 1: Cephalosporinases
|
| 1
|
C
|
cephalosporins
|
—
|
—
|
hydrolyzes cephalosporins better than benzylpenicillin, and hydrolyzes cephamycins
|
E. coli AmpC, P99, ACT-1, CMY-2, FOX-1, MIR-1
|
|
|
cephalosporins
|
—
|
—
|
increased hydrolysis of ceftazidime and other oxyimino-β-lactams
|
GC1, CMY-37
|
| Group 2: β-Lactamases
|
| 2a
|
A
|
penicillins
|
yes
|
—
|
hydrolyzes benzylpenicillin better than cephalosporins
|
PC1
|
| 2b
|
penicillins and early cephalosporins
|
yes
|
—
|
hydrolyzes benzylpenicillin similar to cephalosporins
|
TEM-1, TEM-2, SHV-1
|
| 2be
|
extended-spectrum cephalosporins, monobactams
|
yes
|
—
|
increased hydrolysis of oxyimino-β-lactams (third-generation plus monobactams)
|
TEM-3, SHV-2, CTX-M-15, PER-1, VEB-1
|
| 2br
|
penicillins
|
—
|
—
|
resistance to clavulanic acid, sulbactam, and tazobactam
|
TEM-30, SHV-10
|
| 2ber
|
extended-spectrum cephalosporins, monobactams
|
—
|
—
|
increased hydrolysis of oxyimino-β-lactams plus resistance to clavulanic acid, sulbactam, and tazobactam
|
TEM-50
|
| 2c
|
carbenicillin
|
yes
|
—
|
increased hydrolysis of carbenicillin
|
PSE-1, CARB-3
|
| 2ce
|
carbenicillin, cefepime
|
yes
|
—
|
increased hydrolysis of carbenicillin, cefepime, and cefpirome
|
RTG-4
|
| 2d
|
D
|
cloxacillin
|
variable
|
—
|
increased hydrolysis of cloxacillin or oxacillin
|
OXA-1, OXA-10
|
| 2de
|
extended-spectrum cephalosporins
|
variable
|
—
|
hydrolyzes cloxacillin or oxacillin and oxyimino-β-lactams
|
OXA-11, OXA-15
|
| 2df
|
carbapenems
|
variable
|
—
|
hydrolyzes cloxacillin or oxacillin and carbapenems
|
OXA-23, OXA-48
|
| 2e
|
A
|
extended-spectrum cephalosporins
|
yes
|
—
|
hydrolyzes cephalosporins, and inhibited by clavulanic acid but not aztreonem
|
CepA
|
| 2f
|
carbapenems
|
variable
|
—
|
increased hydrolysis of carbapenems, oxyimino-β-lactams, cephamycins
|
KPC-2, IMI-1, SME-1
|
| Group 3: Carbapenemases
|
| 3a
|
B
|
carbapenems
|
—
|
yes
|
broad-spectrum hydrolysis including carbapenems but not monobactams
|
IMP-1, VIM-1, CcrA, IND-1, L1, CAU-1, GOB-1, FEZ-1
|
| 3b
|
carbapenems
|
—
|
yes
|
preferential hydrolysis of carbapenems
|
CphA, Sfh-1
|
Epidemiology
- The most common β-lactamase is TEM-1
- The most common carbapenemases in the US are KPCs, followed by NDM and OXA-48-like carbapenemases
Common β-Lactamases
| β-lactamase1
|
AMX
|
AMC
|
TIC
|
TIM
|
PIP
|
TZP
|
CFZ
|
FOX
|
CRO
|
| TEM-1
|
R
|
S
|
R
|
S
|
I/R
|
S
|
S/I/R
|
S
|
S
|
| TEM-1 hyperproduction
|
R
|
I/R
|
R
|
I/R
|
R
|
S/I/R
|
I/R
|
S
|
S
|
| OXA-1
|
R
|
I/R
|
R
|
I/R
|
R
|
I/R
|
R
|
S
|
S
|
| IRT type
|
R
|
I/R
|
I/R
|
I/R
|
S/I/R
|
S/I/R
|
S
|
S
|
S
|
| CMT type
|
R
|
R
|
R
|
I/R
|
R
|
I/R
|
I/R
|
S
|
I/R
|
| ESBL type
|
R
|
S/I
|
R
|
S
|
I/R
|
S/I
|
R
|
S
|
R
|
| AmpC hyperproduction
|
R
|
R
|
I/R
|
I/R
|
I/R
|
I/R
|
R
|
I/R
|
S/I/R
|
Management
Further Reading
- Updated Functional Classification of β-Lactamases. Antimicrob Agents Chemother. 2010;54(3):969-976. doi: 10.1128/AAC.01009-09
References
- ^ R. Cantón, M.I. Morosini, O. Martin, S. de la Maza, E. Gomez G. de la Pedrosa. IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. 2008;14:53-62. doi:10.1111/j.1469-0691.2007.01849.x.